Ara
Toplam kayıt 1, listelenen: 1-1
Evaluation of the effect of a novel β3-adrenergic agonist on choroidal vascularity
(2021)
PURPOSE. To determine the effect of the new β3-agonist (mirabegron), which is used for overactive bladder (OAB) treatment, on central retinal thickness (CRT) and choroidal vascularity. MATERIAL AND METHODS. The 26 eyes of ...